Status:
COMPLETED
Fructo-oligosaccharides and Irritable Bowel Syndrome
Lead Sponsor:
Beghin-Meiji
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Fructo-oligosaccharides are known as prebiotic ingredients to modulate the composition of the intestinal microbiota and particularly to stimulate the growth of Bifidobacteria. Imbalance of the intesti...
Eligibility Criteria
Inclusion
- IBS subjects according to Rome III criteria
- Incomfort below or equivalent to 30mmHg during Tensostat test
- between 18 and 60 years
- no antibiotic treatment for the last 2 months
- less than 20g of dietary fibres consummed per day
- no analgesic treatment
- no treatment for intestinal transit
Exclusion
- subjects suffering from diabetes, colic cancer, inflammatory bowel disease, dysthyroidy, Hirschprung disease, anorexia
- excessive consumption of alcohol or tobacco
- participating to another clinical study
- pregnant women
- antidepressor or anxiolytic treatment
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00806104
Start Date
March 1 2009
End Date
December 1 2010
Last Update
January 17 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont Ferrand
Clermont-Ferrand, France, 63003
2
Vall Hebron Hospital
Barcelona, Spain, 08035